en
E-mail us
About Us
Crystal Pharmatech

Crystal Pharmatech, established in 2010, is a global company with approximately 250 employees and three R&D centers located in Suzhou (China), New Jersey (USA), and Toronto (Canada). Our key differentiator is our integrated and specialized services, including API solid-state research, crystallization, preformulation, formulation development, and manufacturing.

Know More
20+
R & D Experience
120,000ft²
R&D And GMP Facility Area
1,000+
Clients
2,000+
Projects
Mol2Med™ Integrated Services Mol2Med™ Integrated Services
Mol2Med™ Integrated Services
This innovative approach guarantees a robust API form and a scalable manufacturing process, culminating in a First-Time-Right formulation for Phase I. Streamlining the transition to future clinical studies upon Phase I success, our First-Time-Right approach sets the foundation for optimized drug development and success beyond.
Developability Assessment Developability Assessment
Developability Assessment
Based on industry-wide best practices, we offer a quantitative Developability Assessment to understand and rank customers' lead candidates by determining key physicochemical parameters, solubility and stability, etc.
API Form and Solid-State Research API Form and Solid-State Research
API Form and Solid-State Research
We employ an integrated approach to identify and develop the best solid form for your small molecules through effective screening and rigorous physicochemical properties assessments.
Crystallization Development Crystallization Development
Crystallization Development
We leverage deep understanding of physicochemical and engineering principles, and expensive experience to help customers develop a robust and ecomocial crystallization process ensuring appropriate quality attributes.
Pre-formulation Studies Pre-formulation Studies
Pre-formulation Studies
Having a thorough understanding on API's physiochemical properties is critical for developing appropriate formulation and process to support both non-clinical and clinical studies. Once API is available, conducting preformulation studies to collect data on API properties is the first step to assemble the preformulation data package in order to design the formulation route.
Formulation and Analytical Development Formulation and Analytical Development
Formulation and Analytical Development
In Crystal Pharmtech, instead of one-size-fit-all platforms or “super-placebo” or quick and rough “fit-for-purpose” formulation approaches in early development, we apply a “First-Time-Right” strategy for formulation development to accelerate your molecule to First in Human (FIH) studies and onward to commercialization at a cost-effective and time-saving way.
GMP Manufacturing GMP Manufacturing
GMP Manufacturing
Crystal Pharmatech offers a full spectrum of commercial manufacturing and packaging services covering a wide variety of dosage forms. We have the capabilities, experienced talents and innovative technologies to support you in delivering your product to market.
Clinical Supply Clinical Supply
Clinical Supply
Crystal Pharmatech provides a one-stop Clinical Supply Service from pre-clinical to post-marketing.
Competitive Advantages of Crystal Pharmatech
Extensive Experience & Proven Track Record
  • A leading expert in Solid- State Research, Pre-formulation, Formulation Development and Manufacturing.

  • Performed solid form screening and crystallization of over 2,000 drug molecules over 12 years for more than 1,000 clients.

  • Supported 8 out of the top 10 multinational pharmaceutical companies in the area of solid-state research, pre-formulation, formulation development and manufacturing.

  • Strong technical team with >20 years of experience of delivering 100+ early phase and 30+ commercialized products at global pharma.

Innovative Technology
  • World's leading technology supports in-depth understanding of molecule properties and optimal design and development of API solid form and formulation that is tailored to every unique molecule.

  • Molecule-material-medicine (MMM) driven formulation strategy expertise in enabling formulation development.

  • Specialize in mini-tablet pediatric formulation

  • QbD-based versatile and strong agile manufacturing capability, one-stop shop from preclinical to commercial manufacturing.

Practical and Tailored Solutions
  • Provide solutions based on solid science and quality data and guide clients to make the best decision for their precious molecules.

  • cGMP facility and QMS that met NMPA, FDA, and EMA regulatory requirements.

  • Bridge the gap between API and Formulation that de-risk your assets.

  • Integrated clinical formulation development process from bulk manufacturing to packaging and supply.

  • Accelerate your molecule development to the clinic.

Global Resources
  • R&D Center in USA, Canada, and China.

  • Leverage all business units within Crystal Pharmatech.

Extensive Experience & Proven Track Record
Innovative Technology
Practical and Tailored Solutions
Global Resources
Review of Polymorph Patent Application of 30 Small Molecule New Drugs Approved by the FDA in 2023
Review of Polymorph Patent Application of 30 Small Molecule New Drugs Approved by the FDA in 2023
In 2023, the FDA's Center for Drug Evaluation and Research (CDER) approved a total of 55 new drugs, which included 38 new molecular entities, of which 30 were small molecule drugs. In terms of adm...
26 Feb 2024
CATUG and Crystal Bio Establish Strategic Partnership, Launching “CATUG-Crystal” Joint Lab Dedicated to Advanced Nucleic Acid Analytical Services
CATUG and Crystal Bio Establish Strategic Partnership, Launching “CATUG-Crystal” Joint Lab Dedicated to Advanced Nucleic Acid Analytical Services
CAMBRIDGE, Massachusetts & CRANBURY, New Jersey, February 21, 2024, – CATUG Inc. (CATUG) and Crystal Bio, a member of Crystal Pharmatech, announced today a long-term strategic partnership to prov...
21 Feb 2024
Development and Production Application Cases of Amorphous Solid Dispersion Formulations (II) - Spray Drying
Development and Production Application Cases of Amorphous Solid Dispersion Formulations (II) - Spray Drying
In the preceding article, we discussed the application of hot-melt extrusion technology in developing amorphous solid dispersions (ASD) for pharmaceutical formulations. The process involves dispersing...
30 Jan 2024
Customer Testimonials
Leading Drug Discovery Company

"It was great working with the Crystal Pharmatech team on this project – we were very impressed with the speed, responsiveness and high quality of the data, project updates, and final report. We definitely look forward to working with you again in the future!"

Director, Preclinical Development
Small Pharmaceutical Company

"For a small company, cost is always an issue, but so is the use of scarce materials from early stage programs. Crystal Pharmatech has so far delivered a huge amount of work at a very competitive price, and at the same time, has been parsimonious with the supply of materials sent (API, standards, etc.).  I look forward to working with you on our current and future projects."

CMC Head
Non-Profit Organization

"It is a pleasure to work with Crystal Pharmatech. The quality of the data is outstanding, they have shown proactivity in investigating further an issue we had with a project, they always give suggestions on what should/could be the next step, without pushing. This is what a client looks for in a CRO, but rarely finds. The updates are sent regularly and the team is always very responsive when follow-up questions are asked. The final reports are very clear, instructive, and helpful for the project director in order to come to conclusion and/or plan next steps.


Communication is very effective, timely, concise, and to the point. When they don’t hear from us they gently send reminders, and that helps in busy times. It is very difficult to give suggestions on how to improve, when so far the collaboration has been greatly smooth. Keep it up! And thanks for your help with our projects."

Director, Medicinal Chemistry
Small Drug Discovery Company

"Thanks to the Crystal Pharmatech team for this comprehensive write-up of the formulation studies with our compound and the very diligent work in running the studies under a compressed timeframe."

Senior Formulation Consultant
Mid-sized Pharmaceutical Company

"I had a great first experience with Crystal Pharmatech. Tasks were completed rapidly and completely, questions were answered rapidly and data was presented clearly. It was exactly what I had hoped for and more than I expected based on the pricing. I have paid more and received less from many other companies conducting this kind of work. I was very satisfied and look forward to working with Crystal Pharmatech in the future."

Senior Associate Scientist
API Manufacturer

"I keep looking for the next opportunity as your team added a ton of value and I know they will do the same with anything else they would work on.


We implemented a modified version of the process your team developed and it worked perfectly. Thanks again for the quality work your team did on this project."


Associate Director Process Research & Development
Start-up Biotech Company

"Overall quality is very good. We are satisfied with the data and report quality. Although the problem is usually complicated, your service does help on solving it."

Founder
Contact Us
bd_global@crystalpharmatech.com +1-609-604-8303
U.S
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
Suite B4-101, Biobay, 218 Xinghu Street, Suzhou Industrial Park, Suzhou, China, 215123
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
bd_global@crystalpharmatech.com +1-609-604-8303